Dietary sodium and cardiovascular disease

Area of Science:

• Nutrition Science
• Cardiovascular Health
• Public Health Guidelines

Background:

• Higher sodium intake is linked to increased blood pressure (BP), underpinning current population-wide sodium restriction guidelines.
• While short-term trials achieve low sodium intake (<2.0 g/day), long-term reproducibility (>6 months) remains unproven.
• Existing guidelines assume reduced BP and cardiovascular disease (CVD) risk with low sodium intake compared to moderate intake.

Purpose of the Study:

• To evaluate the association between varying sodium intake levels and cardiovascular disease (CVD) risk.
• To critically assess the evidence supporting current sodium restriction guidelines in relation to long-term health outcomes.
• To determine the optimal sodium intake range for cardiovascular disease (CVD) prevention in the general population.

Main Methods:

• Review of current clinical trial data and observational evidence on sodium intake and its effects on BP and CVD.
• Analysis of the J-shaped association observed in epidemiological studies linking sodium intake to CVD risk.
• Consideration of potential adverse effects of very low sodium intake, including neurohormonal changes.

Main Results:

• Observational data suggest a J-shaped curve for sodium intake and CVD risk, with lowest risk at 3-5 g/day.
• Higher sodium intake (>5 g/day) is associated with increased CVD risk, consistent with current guidelines.
• Very low sodium intake (<3 g/day) may be associated with increased risk, potentially due to adverse physiological responses.

Conclusions:

• Current evidence suggests that moderate sodium intake (3-5 g/day) may be optimal for CVD prevention.
• The long-term benefits of strict sodium restriction (<2.0 g/day) require further investigation through large, randomized clinical trials.
• Existing guidelines may need revision pending robust long-term data on sodium intake and cardiovascular outcomes.